NCT00973934View on ClinicalTrials.gov

Magnetic Seizure Therapy (MST) for the Treatment of Major Depression

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

January 31, 2006

Study Completion Date

December 31, 2009

Conditions
Major Depressive Disorder
Interventions
DEVICE

Magstim Theta

DEVICE

Thymatron System IV

Trial Locations (2)

27710

Duke Universtiy Medical Center, Durham

75390

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

University of Texas

OTHER

collaborator

Stanley Medical Research Institute

OTHER

lead

Sarah Lisanby

OTHER

NCT00973934 - Magnetic Seizure Therapy (MST) for the Treatment of Major Depression | Biotech Hunter | Biotech Hunter